Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Puma Biotechnology Inc.

    NASDAQ: PBYI · Real-Time Price · USD
    3.71
    0.06 (1.64%)
    At close: Jun 06, 2025, 3:59 PM
    3.72
    0.13%
    After-hours: Jun 06, 2025, 04:04 PM EDT

    Puma Biotechnology Statistics

    Share Statistics

    Puma Biotechnology has 49.64M shares outstanding. The number of shares has increased by 2.84% in one year.

    Shares Outstanding

    n/a
    		 49.64M

    Shares Change (YoY)

    n/a
    		 2.84%

    Shares Change (QoQ)

    n/a
    		 1.07%

    Owned by Institutions (%)

    n/a
    		 59.6%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 2,847

    FTD / Avg. Volume

    n/a
    		 0.76%

    Short Selling Information

    The latest short interest is 2.87M, so 5.78% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.87M

    Short % of Shares Out

    n/a
    		 5.78%

    Short % of Float

    n/a
    		 6.77%

    Short Ratio (days to cover)

    n/a
    		 7.42

    Valuation Ratios

    The PE ratio is 4.9 and the forward PE ratio is 11.11. Puma Biotechnology's PEG ratio is 0.14.

    PE Ratio

    n/a
    		 4.9

    Forward PE

    n/a
    		 11.11

    PS Ratio

    n/a
    		 0.64

    Forward PS

    n/a
    		 0.9

    PB Ratio

    n/a
    		 1.61

    P/FCF Ratio

    n/a
    		 3.82

    PEG Ratio

    n/a
    		 0.14
    Financial Ratio History

    Enterprise Valuation

    Puma Biotechnology has an Enterprise Value (EV) of 153.24M.

    EV / Sales

    n/a
    		 0.66

    EV / EBITDA

    n/a
    		 3.19

    EV / EBIT

    n/a
    		 3.94

    EV / FCF

    n/a
    		 3.94

    Financial Position

    The company has a current ratio of 1.54, with a Debt / Equity ratio of 0.8.

    Current Ratio

    n/a
    		 1.54

    Quick Ratio

    n/a
    		 1.45

    Debt / Equity

    n/a
    		 0.8

    Debt / EBITDA

    n/a
    		 1.54

    Debt / FCF

    n/a
    		 1.91

    Interest Coverage

    n/a
    		 2.49

    Financial Efficiency

    Return on Equity is 32.87% and Return on Invested Capital is 23.14%.

    Return on Equity

    n/a
    		 32.87%

    Return on Assets

    n/a
    		 14.19%

    Return on Invested Capital

    n/a
    		 23.14%

    Revenue Per Employee

    n/a
    		 $1,339,930.23

    Profits Per Employee

    n/a
    		 $176,034.88

    Employee Count

    n/a
    		 172

    Asset Turnover

    n/a
    		 1.08

    Inventory Turnover

    n/a
    		 7.38

    Taxes

    Income Tax

    n/a
    		 -6.18M

    Effective Tax Rate

    n/a
    		 -25.63%

    Stock Price Statistics

    The stock price has increased by 2.53% in the last 52 weeks. The beta is 1.28, so Puma Biotechnology's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.28

    52-Week Price Change

    n/a
    		 2.53%

    50-Day Moving Average

    n/a
    		 3.11

    200-Day Moving Average

    n/a
    		 2.96

    Relative Strength Index (RSI)

    n/a
    		 63.82

    Average Volume (20 Days)

    n/a
    		 375,201

    Income Statement

    In the last 12 months, Puma Biotechnology had revenue of 230.47M and earned 30.28M in profits. Earnings per share was 0.62.

    Revenue

    n/a
    		 230.47M

    Gross Profit

    n/a
    		 166.06M

    Operating Income

    n/a
    		 30.97M

    Net Income

    n/a
    		 30.28M

    EBITDA

    n/a
    		 48.08M

    EBIT

    n/a
    		 36.55M

    Earnings Per Share (EPS)

    n/a
    		 0.62
    Full Income Statement

    Balance Sheet

    The company has 69.22M in cash and 74.08M in debt, giving a net cash position of -4.86M.

    Cash & Cash Equivalents

    n/a
    		 69.22M

    Total Debt

    n/a
    		 74.08M

    Net Cash

    n/a
    		 -4.86M

    Retained Earnings

    n/a
    		 -1.31B

    Total Assets

    n/a
    		 196.18M

    Working Capital

    n/a
    		 45.85M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 38.92M and capital expenditures -56K, giving a free cash flow of 38.86M.

    Operating Cash Flow

    n/a
    		 38.92M

    Capital Expenditures

    n/a
    		 -56K

    Free Cash Flow

    n/a
    		 38.86M

    FCF Per Share

    n/a
    		 0.8
    Full Cash Flow Statement

    Margins

    Gross margin is 72.06%, with operating and profit margins of 13.44% and 13.14%.

    Gross Margin

    n/a
    		 72.06%

    Operating Margin

    n/a
    		 13.44%

    Pretax Margin

    n/a
    		 10.46%

    Profit Margin

    n/a
    		 13.14%

    EBITDA Margin

    n/a
    		 20.86%

    EBIT Margin

    n/a
    		 13.44%

    FCF Margin

    n/a
    		 16.86%

    Dividends & Yields

    PBYI does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 20.41%

    FCF Yield

    n/a
    		 26.19%
    Dividend Details

    Analyst Forecast

    The average price target for PBYI is $7, which is 91.8% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $7

    Price Target Difference

    n/a
    		 91.8%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 5.15

    Graham Upside

    n/a
    		 41.1%

    Scores

    Altman Z-Score

    n/a
    		 -6.18

    Piotroski F-Score

    n/a
    		 7

    Add to Watchlist